There are several strategies for the early detection of prostate cancer. The first step is often a blood test for prostate-specific antigen (PSA). If PSA levels exceed a certain threshold, the next ...

Using prostate MRI before a biopsy is a real advance in prostate cancer diagnosis. Multiple randomized trials have shown that imaging the ...

Although mpMRI can improve targeting of clinically significant prostate cancer, its performance depends in part on obtaining ...

Abbreviated biparametric MRI was noninferior to full multiparametric MRI in detecting clinically significant prostate cancer in the prospective PRIME study, suggesting that it could become the new ...

In a cohort of US veterans with prostate cancer who were on active surveillance, negative multiparametric MRI had a 75% negative predictive value for ruling out disease of grade group 2 or higher at ...

A large screening trial showed that using prostate-specific antigen density (PSAD) before MRI prevented overdiagnosis and lowered resource use while preserving the detection of clinically significant ...

New research published in JAMA Network Open shows that magnetic resonance imaging (MRI)-based risk calculators can predict prostate cancer risk among adults in Europe and North America with some ...

Integrating magnetic resonance imaging (MRI) into prostate cancer (PCa) screening is associated with a reduction in unnecessary biopsies and overdiagnosis of insignificant disease, according to a ...

Using MRI as a screening test alongside PSA density allowed detection of cancers that would have been missed by the blood test alone, according to new research. The REIMAGINE study, published today in ...

Active surveillance for prostate cancer isn't about doing nothing — it's a structured plan of regular testing and check-ins. A urologic oncologist breaks down what patients can expect, and the ...